Skip to content

GenkiMed

Active Private limited companyfounded 2023active for 3 yearsBien-Fairestraat 61, 1170 Watermael-BoitsfortKBO/BCE: BE 0800.308.594

Timeline

7 events since 2023

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 51 days before the deadline
2025
Liquidity more than doubled current ratio 3.66 The current ratio rises from 1.67 to 3.66. Short-term debt falls from €33,195 to €21,788.
Annual accounts 2024 filed PDFmicro format · 45 days before the deadline
2024
Highest result from 2023 to 2025 net €43,978 ▲3,111% The operating result of €55,164 and the net result of €43,978 are both a record.
Annual accounts 2023 filed PDFmicro format · 47 days before the deadline
2023
IncorporationFounded by (comparante) · 100 shares · appointed as director · published on 05-04-20235 points ▸
  • The registered office is at Rue du Bien-Faire 61, 1170 Watermael-Boitsfort
  • The board has one director
  • appointed as director, not named in the articles
  • Founded by
  • The capital is divided into 100 shares
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

GenkiMed was incorporated on 3 April 2023 as a private limited company by one private individual.12 Since 2023, has served as director.3 Total assets rose from €19,029 in 2023 to €100,783 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 05-04-2023
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2023 and 2025

Next steps